All News #Library
Rare Diseases
AlveoGene’s Inhaled Therapy AVG-002 Gets FDA Orphan Designation
03 Dec 2024 //
GLOBENEWSWIRE
AlveoGene Gets FDA Rare Pediatric Disease Designation for AVG-002
15 Nov 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support